Yakup Ergün
-
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 5
-
- Breast Cancer Treatment Studies 5
-
- Gastric Cancer Management and Outcomes 8
-
- Genetic factors in colorectal cancer 5
-
- Colorectal and Anal Carcinomas 6
- Co-authors
- Gökhan UçarBaran AkagündüzDoğan UncuÖznur BalCengiz KaraçinNuriye ÖzdemirMutlu DoğanBerna Öksüzoğlu
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
Yakup Ergün
32 papers receiving 178 citations
Peers
Comparison fields: 5 of 45
- Oncology 122
- Cancer Research 62
- Pulmonary and Respiratory Medicine 58
- Hepatology 12
- Pathology and Forensic Medicine 20
Countries citing papers authored by Yakup Ergün
This map shows the geographic impact of Yakup Ergün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yakup Ergün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yakup Ergün more than expected).
Fields of papers citing papers by Yakup Ergün
This network shows the impact of papers produced by Yakup Ergün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yakup Ergün. The network helps show where Yakup Ergün may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yakup Ergün, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 35 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 0 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 4 | |
| 19 | 2020 | 12 | |
| 20 | Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer? | 2020 | 1 |
About Yakup Ergün
Yakup Ergün is a scholar working on Oncology, Health Informatics and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 181 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (8 papers), Cancer Treatment and Pharmacology (7 papers), Colorectal and Anal Carcinomas (6 papers), HER2/EGFR in Cancer Research (5 papers), Genetic factors in colorectal cancer (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (122 citations), Cancer Research (62 citations) and Pulmonary and Respiratory Medicine (58 citations). Yakup Ergün has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Gökhan Uçar, Baran Akagündüz, Doğan Uncu, Öznur Bal, Cengiz Karaçin, Nuriye Özdemir, Mutlu Doğan, Berna Öksüzoğlu, Ozan Yazıcı and Mehmet Alı Nahıt Şendur. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.